Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more

Release Date:

Editor’s Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the June 11, 2024, issue.

Prognostic Value of CV Biomarkers, End Points in Cancer Screening Trials, USPSTF on Breast Cancer Screening, and more

Title
Alirocumab for Coronary Atherosclerosis, Flying Stroke Intervention Team, USPSTF Recommendation on COPD Screening, and more
Copyright
Release Date

flashback